Just diagnosed with Metachromatic leukodystrophy?
You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Metachromatic leukodystrophy, look for clinical trials, and connect with others living with it — all in one place.
Open the full interactive Metachromatic leukodystrophy hub →Overview
Metachromatic leukodystrophy is a rare condition. Also known as Arylsulfatase A deficiency, MLD. Tomeko brings together the specialists, research, clinical trials, treatments and community for Metachromatic leukodystrophy so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.
Identifiers: ORPHA:512 · OMIM 156310, 249900, 250100 · ICD-10 E75.2 · GARD 0003230
Find care for Metachromatic leukodystrophy
Authoritative references for Metachromatic leukodystrophy
Research & market landscape for Metachromatic leukodystrophy
Following Metachromatic leukodystrophy for research or industry? Tomeko brings together the recruiting trials, the latest literature, patient organizations, and the specialist and care-center footprint for Metachromatic leukodystrophy — the real-world landscape behind the condition, in one place.
- Latest Metachromatic leukodystrophy research on PubMed ↗
- Recruiting Metachromatic leukodystrophy trials on ClinicalTrials.gov ↗
- Explore the Metachromatic leukodystrophy research & specialist footprint on Tomeko
Researchers, patient organizations & industry: Tomeko provides de-identified, no-PHI demand and engagement signal, trial awareness, and a labeled, editorially-firewalled presence for Metachromatic leukodystrophy and every rare condition. See how Tomeko works with industry →
Common questions
What is Metachromatic leukodystrophy?
Metachromatic leukodystrophy is a rare condition. Also known as Arylsulfatase A deficiency, MLD. For an authoritative medical description see the reference sources on this page; Tomeko brings the specialists, clinical trials, patient organizations and community for Metachromatic leukodystrophy together in one place.
What are the symptoms of Metachromatic leukodystrophy?
Symptoms of Metachromatic leukodystrophy vary from person to person. For a reviewed, plain-language overview see the authoritative references below (NIH GARD, Orphanet), and discuss your own symptoms with a clinician who treats Metachromatic leukodystrophy.
How is Metachromatic leukodystrophy treated?
Treatment for Metachromatic leukodystrophy depends on the individual and is managed by specialists. Use Tomeko to find clinicians and Centers of Excellence who see Metachromatic leukodystrophy, and review current options with them.
What causes Metachromatic leukodystrophy — is it genetic?
The cause and inheritance of Metachromatic leukodystrophy are described in the authoritative references linked on this page. A genetics or specialist clinician who treats Metachromatic leukodystrophy can explain what it means for you and your family.
I was just diagnosed with Metachromatic leukodystrophy — what should I do first?
Start by learning the basics from an authoritative source, find a specialist or center that sees Metachromatic leukodystrophy, and connect with a patient organization. Tomeko brings these together on one hub.
Where can I find a specialist for Metachromatic leukodystrophy?
Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Metachromatic leukodystrophy, filtered to your area.
Are there clinical trials for Metachromatic leukodystrophy?
Tomeko shows live, recruiting studies for Metachromatic leukodystrophy from ClinicalTrials.gov on the hub.
Related conditions
Other conditions on Tomeko you may be looking for:
- 2-aminoadipic 2-oxoadipic aciduria
- 3 beta-Hydroxysteroid dehydrogenase deficiency
- 3-hydroxy-3-methylglutaryl-CoA synthase deficiency
- 3-Hydroxyisobutyric aciduria
- 3-hydroxyisobutyryl-CoA hydrolase deficiency
- 3-methylglutaconic aciduria type 1
- 3-Methylglutaconic aciduria type 2
- 3-Methylglutaconic aciduria type 3